Loading clinical trials...
Loading clinical trials...
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
NCT07540338 · Bipolar I Disorder
NCT07494305 · Bipolar I Disorder
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT07288320 · Bipolar I Disorder, Mania
NCT07213466 · Bipolar I Disorder, Bipolar II Disorder, and more
Local Institution
Scottsdale, Arizona
Local Institution
Little Rock, Arkansas
Local Institution
Chula Vista, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions